CTKBCytek Biosciences, Inc.
$5.59+36% 1Y
$5.59
$3.3652 weeks$6.09
Is the price fair?
What CTKB's price assumes
Cytek Biosciences, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.77× revenue.
2.77
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.78
Price / book · as of 2026-Q2
- EV / sales
- 1.51
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.78
- EV / EBIToperating margin −22%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 1.51
- Market capitalisation130.0 million shares, counted Jul 31, 2026
- $727M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.